review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1002/(SICI)1098-1128(199607)16:4<319::AID-MED2>3.0.CO;2-# |
P698 | PubMed publication ID | 8798178 |
P2093 | author name string | Crooke ST | |
P433 | issue | 4 | |
P304 | page(s) | 319-344 | |
P577 | publication date | 1996-07-01 | |
P1433 | published in | Medicinal Research Reviews | Q2436033 |
P1476 | title | Progress in antisense therapeutics | |
P478 | volume | 16 |
Q40770171 | Antisense Oligodeoxynucleotide Technology: Potential Use for the Treatment of Malignant Brain Tumors |
Q33693109 | Antisense--time to shoot the messenger |
Q38001940 | Cap-dependent translation initiation factor eIF4E: an emerging anticancer drug target |
Q48133876 | Chromatographic approaches for the characterization and quality control of therapeutic oligonucleotide impurities. |
Q40787828 | Comparative inhibitory potential of differently modified antisense oligodeoxynucleotides on hepatitis C virus translation |
Q30453773 | Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides. |
Q36868031 | Phosphorothioate antisense oligonucleotides induce the formation of nuclear bodies |
Q34674518 | Structural characteristics of 2'-O-(2-methoxyethyl)-modified nucleic acids from molecular dynamics simulations |
Q73895553 | Synthesis and hybridization properties of polyamide based nucleic acid analogues incorporating pyrrolidine-derived nucleoamino acids |
Q77373806 | Synthesis of an antisense oligonucleotide targeted against C-raf kinase: efficient oligonucleotide synthesis without chlorinated solvents |
Q44959061 | Synthesis of new OBAN's and further studies on positioning of the catalytic group |
Q43597101 | Synthetic hydrogels as carriers in antisense therapy: preliminary evaluation of an oligodeoxynucleotide covalent conjugate with a copolymer of 1-vinyl-2-pyrrolidinone and 2-hydroxyethyl methacrylate |
Q38344190 | The Influence of Antisense Oligonucleotide-induced RNA Structure on Escherichia coli RNase H1 Activity |
Q34473470 | The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides. |
Search more.